4//SEC Filing
MILESON GLENNA 4
Accession 0001209191-21-012822
CIK 0001620463other
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 5:38 PM ET
Size
5.4 KB
Accession
0001209191-21-012822
Insider Transaction Report
Form 4
MILESON GLENNA
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-02-18+73,500→ 73,500 totalExercise: $21.15Exp: 2031-02-17→ Common Stock (73,500 underlying)
Footnotes (1)
- [F1]One-fourth of the shares subject to the option will vest on January 8, 2022, and one-fourth of the shares subject to the option will vest on each year thereafter.
Documents
Issuer
Athira Pharma, Inc.
CIK 0001620463
Entity typeother
Related Parties
1- filerCIK 0001822241
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 5:38 PM ET
- Size
- 5.4 KB